By Dan Catchpole and Aatreyee Dasgupta (Reuters) -Canadian business jet manufacturer Bombardier (OTC:BDRBF) reported higher first-quarter revenue on Thursday, owing to increased aircraft deliveries and growth in aftermarket services, but the company’s gains fell slightly short of investor expectations. Its shares were down 5% in early trading. Bombardier President and CEO Eric Martel said ...
By Kalea Hall DETROIT (Reuters) -General Motors cut its 2025 profit forecast on Thursday after receiving some clarity and a reprieve from the White House this week on automotive tariffs. CEO Mary Barra told shareholders in a letter that the company would maintain dialogue with the Trump administration on trade and other policies as they evolve. "There are ongoing discussions with key tr ...
By Kenneth Li NEW YORK (Reuters) -Thomson Reuters on Thursday confirmed 2025 financial guidance amid tariff-induced global economic turmoil that has led some companies to revise or scrap forecasts altogether. The Toronto-based content and technology company reported quarterly revenue rising 1% to $1.9 billion, slightly below analyst expectations of $1.93 billion, according to LSEG data. Organic re ...
By Bhanvi Satija and Patrick Wingrove (Reuters) -Eli Lilly on Thursday downplayed CVS Health (NYSE:CVS)’s decision to drop the company’s obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of the drugmaker still fell more than 10%. CVS said its pharmacy benefit management unit, which is the largest in the U.S., would drop Zepbound coverage from July 1, b ...